Bevacizumab and subtype-adapted chemotherapy backbone in neuroendocrine tumors

Julien Hadoux, Michel Ducreux

Résultats de recherche: Contribution à un journal › Letter › Revue par des pairs

5 Citations (Scopus)

langue originale	Anglais
Pages (de - à)	976-977
Nombre de pages	2
journal	Journal of Clinical Oncology
Volume	31
Numéro de publication	7
Les DOIs	https://doi.org/10.1200/JCO.2012.47.0351
état	Publié - 1 mars 2013

Accès au document

@article{15d4bd7416494b8f8badd17f79398831,

title = "Bevacizumab and subtype-adapted chemotherapy backbone in neuroendocrine tumors",

author = "Julien Hadoux and Michel Ducreux",

year = "2013",

month = mar,

day = "1",

doi = "10.1200/JCO.2012.47.0351",

language = "English",

volume = "31",

pages = "976--977",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

number = "7",

}

TY - JOUR

T1 - Bevacizumab and subtype-adapted chemotherapy backbone in neuroendocrine tumors

AU - Hadoux, Julien

AU - Ducreux, Michel

PY - 2013/3/1

Y1 - 2013/3/1

UR - http://www.scopus.com/inward/record.url?scp=84875739360&partnerID=8YFLogxK

U2 - 10.1200/JCO.2012.47.0351

DO - 10.1200/JCO.2012.47.0351

M3 - Letter

C2 - 23358990

AN - SCOPUS:84875739360

SN - 0732-183X

VL - 31

SP - 976

EP - 977

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 7

ER -